Exploring the 3D structure of chromatin in cancer stem cells
Northwestern University Center for Chromatin NanoImaging in Cancer (NU-CCNIC)
This study is looking at how the shape of DNA in cancer cells affects cancer stem cells, which can make tumors tough to treat, and it aims to find new ways to help patients by better understanding these cells.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University NIH-funded |
| Lab location | 1 site (Chicago, UNITED STATES) |
| Project ID | NIH-11003265 on NIH RePORTER |
What this research studies
This research investigates how the three-dimensional structure of chromatin affects cancer stem cells, which are known to contribute to tumor resistance and relapse after treatment. By developing advanced imaging technologies, the project aims to provide detailed insights into the molecular mechanisms that govern cancer stem cell behavior. The research will involve collaboration among experts in various fields, including imaging, genomics, and oncology, to create a comprehensive platform for studying these critical cells. Patients may benefit from improved understanding and potential new therapies targeting cancer stem cells.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with cancers that are known to involve cancer stem cells and exhibit resistance to conventional therapies.
Not a fit: Patients with non-cancerous conditions or those whose cancers do not involve cancer stem cells may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective anti-cancer therapies by targeting the mechanisms that allow cancer stem cells to resist treatment.
How similar studies have performed: Other research has shown promise in using advanced imaging techniques to study cancer biology, indicating that this approach may yield valuable insights.
Where this research is happening
Chicago, UNITED STATES
- Northwestern University — Chicago, United States (Active)
Researchers
- Principal investigator: Backman, Vadim — Northwestern University
- Study coordinator: Backman, Vadim
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.